Top

3 Reasons Why Cloud Contact Centres Are the Next Step in Customer Success

FDA Advisory Panel Narrowly Votes Against New ALS Drug

Bayer plots $1.6B investment at German pharma manufacturing sites, with digital transformation a key component...

Assessing the Future of Bioprocessing

The pipeline of new antibiotics is drying up. A bill in Congress aims to change that.

Tag: disintegrating lansoprazole

FDA, Regulations

Dr. Reddy’s gets FDA nod for orally disintegrating lansoprazole

February 23, 2021

Via: FiercePharma

Dr. Reddy’s Laboratories has introduced an orally disintegrating formulation of lansoprazole to the U.S. market. The new product is the therapeutic equivalent of the Prevacid SoluTab delayed-release tablets sold by Takeda. Lansoprazole is a proton pump inhibitor, a mechanism of […]